TY - JOUR T1 - Strategies for Controlling the Spread of COVID-19 JF - medRxiv DO - 10.1101/2020.06.24.20139014 SP - 2020.06.24.20139014 AU - Eric Forgoston AU - Michael A.S. Thorne Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/25/2020.06.24.20139014.abstract N2 - We consider a deterministic epidemiological compartmental model that includes age and social contact structure for the COVID-19 crisis and explore the consequences of different strategies for easing current lockdown measures that are in place in many countries. We apply the model to the specific circumstances in the state of New Jersey, in the United States of America. As expected, only a rigorous program of testing, tracing and isolation of cases will allow the state to ease its lockdown with a reduced number of deaths. We also find that a slightly earlier date of lockdown, while reducing the number of deaths in the short term, will only reduce the total number of deaths in the long run if the ensuing strategies in easing the lockdown are carried out with the aforementioned test, trace and isolation program. Otherwise, a slightly earlier lockdown will result in increased deaths as the expected second wave of infection sweeps through the state in the coming months.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code written to produce the models will be available upon request and through a github site. ER -